Clinical Trials Technology Creeps Into the 21st Century

Computers have been slow to replace paper in clinical tests of experimental drugs. But the pace of change is finally quickening, as we learned from talking with the CEO of IT shop Phase Forward, which is buying Clarix for $40 million.